|

Balstilmab Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Yuan Yuan1

Indications

  • Metastatic Triple-Negative Breast Carcinoma1
  • Anatomic Stage IV Breast Cancer AJCC v81
  • Breast Cancer1
  • Cancer1

Los Angeles, California1 trial

Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

Cedars-Sinai Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.